Literature DB >> 15218312

Relationship between urokinase-type plasminogen receptor, interleukin-8 gene expression and clinicopathological features in gastric cancer.

Kyung Hee Lee1, Sung Hwa Bae, Jae Lyun Lee, Myung Soo Hyun, Sang Hoon Kim, Sun Kyo Song, Hee Sun Kim.   

Abstract

OBJECTIVE: The serine protease urokinase-type plasminogen (uPA) and its receptor (uPAR) appear to have a major function in tumor invasion and metastasis. Interleukin-8 (IL-8) acts as an angiogenic factor in solid cancer. The purpose of this study was to determine whether the expression of IL-8 and the uPAR gene correlates with clinicopathological parameters in human gastric carcinoma.
METHODS: We examined the expression of uPAR mRNA and IL-8 mRNA using Northern blot analysis and RT-PCR in 35 gastric carcinomas and the surrounding normal mucosa. Macroscopic and histopathological tumor findings and survival rates were obtained from the patient records.
RESULTS: uPAR and IL-8 mRNA expression levels were higher in most neoplasms compared to the corresponding normal mucosal tissue. A correlation between uPAR and IL-8 expression in tumors was observed (r = 0.447, p < 0.01). uPAR mRNA expression in the tumors correlated well with lymph node metastasis (p < 0.02), and its stage (p < 0.01). The IL-8 MRNA expression in the tumors correlated with diffuse-type gastric cancer (p < 0.05). The survival rates of patients with tumors displaying high uPAR expression levels were significantly lower (p < 0.04) than those of patients without uPAR expression, but patients with IL-8 expression only showed a tendency to a lower survival rate.
CONCLUSION: These results suggest that uPAR and IL-8 may be important prognostic factors in human gastric carcinomas. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15218312     DOI: 10.1159/000077997

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  23 in total

1.  Correlative studies on uPA mRNA and uPAR mRNA expression with vascular endothelial growth factor, microvessel density, progression and survival time of patients with gastric cancer.

Authors:  Li Zhang; Zhong-Sheng Zhao; Guo-Qing Ru; Jie Ma
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

2.  Epidermal growth factor receptor inhibition downregulates Helicobacter pylori-induced epithelial inflammatory responses, DNA damage and gastric carcinogenesis.

Authors:  Johanna C Sierra; Mohammad Asim; Thomas G Verriere; M Blanca Piazuelo; Giovanni Suarez; Judith Romero-Gallo; Alberto G Delgado; Lydia E Wroblewski; Daniel P Barry; Richard M Peek; Alain P Gobert; Keith T Wilson
Journal:  Gut       Date:  2017-05-04       Impact factor: 23.059

Review 3.  Human and Helicobacter pylori Interactions Determine the Outcome of Gastric Diseases.

Authors:  Alain P Gobert; Keith T Wilson
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

4.  Role of hepatocyte growth factor/c-Met signaling in regulating urokinase plasminogen activator on invasiveness in human hepatocellular carcinoma: a potential therapeutic target.

Authors:  Kyung Hee Lee; Eun Young Choi; Myung Soo Hyun; Byung Ik Jang; Tae Nyeun Kim; Heon Ju Lee; Jong Yuel Eun; Hong Gin Kim; Sung Soo Yoon; Dong Sik Lee; Jung Hye Kim; Jae-Ryong Kim
Journal:  Clin Exp Metastasis       Date:  2007-11-09       Impact factor: 5.150

Review 5.  Helicobacter pylori and interleukin-8 in gastric cancer.

Authors:  Ko Eun Lee; Pham Ngoc Khoi; Yong Xia; Jung Sun Park; Young Eun Joo; Kyung Keun Kim; Seok Yong Choi; Young Do Jung
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

6.  Predominant mucosal IL-8 mRNA expression in non-cagA Thais is risk for gastric cancer.

Authors:  Sirikan Yamada; Shunji Kato; Takeshi Matsuhisa; Luksana Makonkawkeyoon; Masaru Yoshida; Thiraphat Chakrabandhu; Nirush Lertprasertsuk; Pawit Suttharat; Bandhuphat Chakrabandhu; Shin Nishiumi; Wilaiwan Chongraksut; Takeshi Azuma
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.742

7.  Clinical utility of serum interleukin-8 and interferon-alpha in thyroid diseases.

Authors:  Toral P Kobawala; Girish H Patel; Dhara R Gajjar; Kamini N Patel; Premal B Thakor; Urvi B Parekh; Kirti M Patel; Shilin N Shukla; Pankaj M Shah
Journal:  J Thyroid Res       Date:  2011-03-08

8.  Combined mRNA expression levels of members of the urokinase plasminogen activator (uPA) system correlate with disease-associated survival of soft-tissue sarcoma patients.

Authors:  Matthias Kotzsch; Viktor Magdolen; Thomas Greither; Matthias Kappler; Matthias Bache; Christine Lautenschläger; Susanne Füssel; Alexander W Eckert; Thomas Luther; Gustavo Baretton; Peter Würl; Helge Taubert
Journal:  BMC Cancer       Date:  2011-06-25       Impact factor: 4.430

9.  Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.

Authors:  Hirozumi Sawai; Yuji Okada; Hitoshi Funahashi; Yoichi Matsuo; Hiroki Takahashi; Hiromitsu Takeyama; Tadao Manabe
Journal:  BMC Cell Biol       Date:  2006-02-20       Impact factor: 4.241

Review 10.  Prognostic role of urokinase plasminogen activator receptor in gastric and colorectal cancer: A systematic review and meta-analysis.

Authors:  Hong Guo; Chun Ling; Yun-Yun Ma; Lan-Xia Zhou; Li Zhao
Journal:  Onco Targets Ther       Date:  2015-06-19       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.